Lupin gains tentative FDA approval for Empagliflozin, Linagliptin, Metformin Hydrochloride ER… EP News Bureau Jul 10, 2024 This product will be manufactured at Lupin’s Pithampur facility in India
Lupin gets tentative USFDA nod for empagliflozin and metformin hydrochloride ER tablets EP News Bureau Jan 7, 2021 They are indicated as an adjunct to diet and exercise, to improve glycemic control in adults with type 2 diabetes mellitus
Sun Pharma recalls metformin due to high NDMA levels EP News Bureau Sep 24, 2020 NDMA is classified as a probable human carcinogen based on results from laboratory tests
Alembic Pharmaceuticals receives US FDA’s tentative approval for Empagliflozin and Metformin… EP News Bureau Jul 20, 2020 The tentatively approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Synjardy Tablets of…
Lupin recalls diabetes treatment drug in US Reuters Jul 10, 2020 The company said that it is voluntarily recalling its Metformin Hydrochloride extended-release tablets USP, 500 mg and 1000 mg…
Indian pharma firms recall medications from US market Press Trust of India Jul 5, 2020 Lupin and Marksans Pharma recall diabetes drugs while Alembic and Aurbindo recall medicines that treat mental disorders
Glenmark Pharma gets USFDA nod for diabetes management drug Press Trust of India Nov 27, 2019 The company's current portfolio consists of 164 products authorised for distribution in the US marketplace and 44 abbreviated new…